Your browser doesn't support javascript.
loading
The prognostic importance of the angiotensin II/angiotensin-(1-7) ratio in patients with SARS-CoV-2 infection.
Amezcua-Guerra, Luis M; Del Valle, Leonardo; González-Pacheco, Héctor; Springall, Rashidi; Márquez-Velasco, Ricardo; Massó, Felipe; Brianza-Padilla, Malinalli; Manzur-Sandoval, Daniel; González-Flores, Julieta; García-Ávila, Carlos; Juárez-Vicuña, Yaneli; Sánchez-Muñoz, Fausto; Ballinas-Verdugo, Martha A; Basilio-Gálvez, Edna; Paez-Arenas, Araceli; Castillo-Salazar, Mauricio; Cásares-Alvarado, Sergio; Hernández-Diazcouder, Adrián; Sánchez-Gloria, José L; Tavera-Alonso, Claudia; Gopar-Nieto, Rodrigo; Sandoval, Julio.
Afiliação
  • Amezcua-Guerra LM; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Del Valle L; Pharmacology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • González-Pacheco H; Coronary Care Unit, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Springall R; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Márquez-Velasco R; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Massó F; Translational Medicine Lab UNAM-INC Unit, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Brianza-Padilla M; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Manzur-Sandoval D; Intensive Care Unit, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • González-Flores J; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • García-Ávila C; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Juárez-Vicuña Y; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Sánchez-Muñoz F; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Ballinas-Verdugo MA; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Basilio-Gálvez E; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Paez-Arenas A; Translational Medicine Lab UNAM-INC Unit, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Castillo-Salazar M; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Cásares-Alvarado S; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Hernández-Diazcouder A; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Sánchez-Gloria JL; Immunology Department, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Tavera-Alonso C; Core Lab, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Gopar-Nieto R; Coronary Care Unit, Ignacio Chávez National Institute of Cardiology, Mexico City, Mexico.
  • Sandoval J; Immunology Department, Ignacio Chávez National Institute of Cardiology, Juan Badiano # 1, Colonia Sección XVI Tlalpan, México City 14080, México.
Ther Adv Respir Dis ; 16: 17534666221122544, 2022.
Article em En | MEDLINE | ID: mdl-36082632
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiotensina I / Angiotensina II / Enzima de Conversão de Angiotensina 2 / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ther Adv Respir Dis Assunto da revista: PNEUMOLOGIA / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiotensina I / Angiotensina II / Enzima de Conversão de Angiotensina 2 / COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ther Adv Respir Dis Assunto da revista: PNEUMOLOGIA / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México